Creative Planning’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Creative Planning’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,000	Closed	-$102K	–	2170
2020 Q1	$102K	Buy	+2,000	New	+$134K	﹤0.01%	1529
2019 Q1	–	Sell	-73,200	Closed	-$3M	–	2116
2018 Q4	$3M	Buy	73,200 +50,472	+222%	+$1.89M	0.01%	343
2018 Q3	$864K	Sell	22,728 -1	-0%	-$44	﹤0.01%	821
2018 Q2	$1.03M	Buy	+22,729	New	+$1.03M	﹤0.01%	733
2017 Q3	–	Sell	-41,801	Closed	-$1.14M	–	4004
2017 Q2	$1.14M	Buy	41,801 +40,600	+3,381%	+$1.21M	0.01%	623
2017 Q1	$44K	Buy	1,201 +900	+299%	+$22.7K	﹤0.01%	2584
2016 Q4	$4K	Sell	301 -1,000	-77%	-$17.6K	﹤0.01%	4088
2016 Q3	$30K	Hold	1,301	–	–	﹤0.01%	2750
2016 Q2	$22K	Hold	1,301	–	–	﹤0.01%	2739
2016 Q1	$21K	Hold	1,301	–	–	﹤0.01%	2731
2015 Q4	$42K	Buy	+1,301	New	+$56.3K	﹤0.01%	2265

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Creative Planning's GBT Position: Q2 2020 in Review

Creative Planning sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2020, closing a stake of 2,000 shares — an estimated $102K sold.

Creative Planning first reported a position in GBT in Q4 2015 and held it in 11 quarters. The position peaked at $3M in Q4 2018. 253 funds tracked by Wall St. Rank hold GBT as of Q2 2020.

Creative Planning reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Creative Planning sold 2,000 Global Blood Therapeutics, Inc. shares in Q2 2020, an estimated $102K.
Creative Planning first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 11 quarters.
Creative Planning's Global Blood Therapeutics, Inc. position peaked at $3M in Q4 2018.
253 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2020.

Based on Creative Planning's 13F filing for Q2 2020, filed 23 Jul 2020.